UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevention and management of secondary central nervous system lymphoma

Haematologica (Roma), 2023-03, Vol.108 (3), p.673-689

2023

Volltextzugriff (PDF)

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

BMC cancer, 2022-09, Vol.22 (1), p.971-9, Article 971

2022

Volltextzugriff (PDF)

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-09, Vol.12 (1), p.15805-10, Article 15805

2022

Volltextzugriff (PDF)

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

Scientific reports, 2022-12, Vol.12 (1), p.21009-21009, Article 21009

2022

Volltextzugriff (PDF)

How I treat secondary CNS involvement by aggressive lymphomas

Blood, 2023-11, Vol.142 (21), p.1771-1783

2023

Volltextzugriff (PDF)

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Blood cancer journal (New York), 2023-04, Vol.13 (1), p.54-54, Article 54

2023

Volltextzugriff (PDF)

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

Journal of personalized medicine, 2023-07, Vol.13 (7), p.1182

2023

Volltextzugriff (PDF)

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Blood, 2010-11, Vol.116 (22), p.4569-4577

2010

Volltextzugriff (PDF)

Evidence-based management of primary and secondary CNS lymphoma

Seminars in hematology, 2023-11, Vol.60 (5), p.313-321

2023

Volltextzugriff (PDF)

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

Journal of personalized medicine, 2021-08, Vol.11 (9), p.876

2021

Volltextzugriff (PDF)

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

Blood, 2008-11, Vol.112 (9), p.3827-3834

2008

Volltextzugriff (PDF)

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

Blood, 2000-10, Vol.96 (8), p.2712-2716

2000

Volltextzugriff (PDF)

CNS prophylaxis in aggressive B-cell lymphoma

Hematology, 2022-12, Vol.2022 (1), p.138-145

2022

Volltextzugriff (PDF)

2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells

Blood, 2009-08, Vol.114 (6), p.1217-1225

2009

Volltextzugriff (PDF)

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

Blood, 2001-03, Vol.97 (6), p.1560-1565

2001

Volltextzugriff (PDF)

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

Blood, 2003-05, Vol.101 (9), p.3560-3567

2003

Volltextzugriff (PDF)

Extending potentially curative options for older patients with PCNSL

The Lancet. Haematology, 2024-03, Vol.11 (3), p.e171-e173

2024

Volltextzugriff (PDF)

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Blood, 2022-04, Vol.139 (16), p.2499-2511

2022

Volltextzugriff (PDF)

First in Human Study of AUTO4, a TRBC1-Targeting CAR T-Cell Therapy in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.10316-10317

2022

Volltextzugriff (PDF)

CNS prophylaxis for diffuse large B-cell lymphoma

The lancet oncology, 2022-09, Vol.23 (9), p.e416-e426

2022

Volltextzugriff (PDF)

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Nature genetics, 2022-11, Vol.54 (11), p.1675-1689

2022

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

KollektionTaylor & Francis:Master (3349 titles)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(90)
Buchkapitel
(2)

Sprache

Englisch
(92)
Japanisch
(6)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Prevention and management of secondary central nervous system lymphoma

International multicenter retrospective analysis of thiotepa-based autologous stem cell transplantation for secondary central nervous system lymphoma

Optimizing MATRix as remission induction in PCNSL: de-escalated induction treatment in newly diagnosed primary CNS lymphoma

Differentiating central nervous system infection from disease infiltration in hematological malignancy

Author Correction: Differentiating central nervous system infection from disease infiltration in hematological malignancy

How I treat secondary CNS involvement by aggressive lymphomas

A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Evidence-based management of primary and secondary CNS lymphoma

Filtration-Histogram Based Magnetic Resonance Texture Analysis (MRTA) for the Distinction of Primary Central Nervous System Lymphoma and Glioblastoma

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia

CNS prophylaxis in aggressive B-cell lymphoma

2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells

Early detection of BCR-ABL transcripts by quantitative reverse transcriptase–polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemia

Dendritic cells from CML patients have altered actin organization, reduced antigen processing, and impaired migration

Extending potentially curative options for older patients with PCNSL

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients

Ibrutinib and rituximab versus fludarabine, cyclophosphamide, and rituximab for patients with previously untreated chronic lymphocytic leukaemia (FLAIR): interim analysis of a multicentre, open-label, randomised, phase 3 trial

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

First in Human Study of AUTO4, a TRBC1-Targeting CAR T-Cell Therapy in Relapsed/Refractory TRBC1-Positive Peripheral T-Cell Lymphoma

CNS prophylaxis for diffuse large B-cell lymphoma

Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features

Aktive Filter

Suchergebnisse filtern